Skip to Main Content

Paper Details

Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine.
Dig Dis Sci
1
2023
Author NameAffiliation
Gaurav SyalUniversity of California at San Diego
Gil Y MelmedCedars-Sinai Medical Center
Brennan M R SpiegelCedars-Sinai Medical Center
  • 1 - 3

Datasets